Patients in the lowest serum sodium group had a 49% increased risk of dying compared with those who had the highest serum sodium levels.
Lower serum sodium levels in patients initiating peritoneal dialysis (PD) are associated with an increased risk of death, according to a new study published online ahead of print in Peritoneal Dialysis International.
Researchers led by Andrew Davenport, MD, of the Royal Free Hospital in Hampstead, U.K., studied 3108 PD patients enrolled at day 90 of renal replacement therapy into the U.K. Renal Registry database and who had sodium measurements available. After adjusting for covariates, patients in the lowest serum sodium group (137 mmol/L or less) had a 49% increased risk of dying compared with those who had the highest serum sodium levels (140 mmol/L or higher).
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.